These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 16249029)

  • 41. Fluorescent tag is not a reliable marker for small RNA transfection in the presence of serum.
    Han J; Wang QW; Wang SQ
    J Biosci; 2013 Sep; 38(3):471-8. PubMed ID: 23938380
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Potent microRNA suppression by RNA Pol II-transcribed 'Tough Decoy' inhibitors.
    Bak RO; Hollensen AK; Primo MN; Sørensen CD; Mikkelsen JG
    RNA; 2013 Feb; 19(2):280-93. PubMed ID: 23249752
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Microarray-based analysis of gene regulation by transcription factors and microRNAs in glioma.
    Yu J; Cai X; He J; Zhao W; Wang Q; Liu B
    Neurol Sci; 2013 Aug; 34(8):1283-9. PubMed ID: 23212403
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Stressing hematopoiesis and immunity: an acetylcholinesterase window into nervous and immune system interactions.
    Gilboa-Geffen A; Hartmann G; Soreq H
    Front Mol Neurosci; 2012; 5():30. PubMed ID: 22448158
    [TBL] [Abstract][Full Text] [Related]  

  • 45. MicroRNAs in platelet production and activation.
    Edelstein LC; Bray PF
    Blood; 2011 May; 117(20):5289-96. PubMed ID: 21364189
    [TBL] [Abstract][Full Text] [Related]  

  • 46. MicroRNAs challenge the status quo of therapeutic targeting.
    Sayed D; Rane S; Abdellatif M
    J Cardiovasc Transl Res; 2009 Mar; 2(1):100-7. PubMed ID: 20559973
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Identification and characteristics of microRNAs from Bombyx mori.
    He PA; Nie Z; Chen J; Chen J; Lv Z; Sheng Q; Zhou S; Gao X; Kong L; Wu X; Jin Y; Zhang Y
    BMC Genomics; 2008 May; 9():248. PubMed ID: 18507836
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of ret/PTC 1 rearrangement on transcription and post-transcriptional regulation in a papillary thyroid carcinoma model.
    Cahill S; Smyth P; Finn SP; Denning K; Flavin R; O'Regan EM; Li J; Potratz A; Guenther SM; Henfrey R; O'Leary JJ; Sheils O
    Mol Cancer; 2006 Dec; 5():70. PubMed ID: 17156473
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Using synthetic miRNA mimics for diverting cell fate: a possibility of miRNA-based therapeutics?
    Ford LP
    Leuk Res; 2006 May; 30(5):511-3. PubMed ID: 16242778
    [No Abstract]   [Full Text] [Related]  

  • 50. miR-181a and miR-630 regulate cisplatin-induced cancer cell death.
    Galluzzi L; Morselli E; Vitale I; Kepp O; Senovilla L; Criollo A; Servant N; Paccard C; Hupé P; Robert T; Ripoche H; Lazar V; Harel-Bellan A; Dessen P; Barillot E; Kroemer G
    Cancer Res; 2010 Mar; 70(5):1793-803. PubMed ID: 20145152
    [TBL] [Abstract][Full Text] [Related]  

  • 51. MicroRNA-132 potentiates cholinergic anti-inflammatory signaling by targeting acetylcholinesterase.
    Shaked I; Meerson A; Wolf Y; Avni R; Greenberg D; Gilboa-Geffen A; Soreq H
    Immunity; 2009 Dec; 31(6):965-73. PubMed ID: 20005135
    [TBL] [Abstract][Full Text] [Related]  

  • 52. hsa-mir-181a and hsa-mir-181b function as tumor suppressors in human glioma cells.
    Shi L; Cheng Z; Zhang J; Li R; Zhao P; Fu Z; You Y
    Brain Res; 2008 Oct; 1236():185-93. PubMed ID: 18710654
    [TBL] [Abstract][Full Text] [Related]  

  • 53. MicroRNA modulation of megakaryoblast fate involves cholinergic signaling.
    Guimaraes-Sternberg C; Meerson A; Shaked I; Soreq H
    Leuk Res; 2006 May; 30(5):583-95. PubMed ID: 16249029
    [TBL] [Abstract][Full Text] [Related]  

  • 54. MicroRNAs and immunity: novel players in the regulation of normal immune function and inflammation.
    Sonkoly E; Ståhle M; Pivarcsi A
    Semin Cancer Biol; 2008 Apr; 18(2):131-40. PubMed ID: 18291670
    [TBL] [Abstract][Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.